TOL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Toleranzia AB is a biotechnology company. It engages in the research and development of drugs that utilize the immune system power to treat autoimmune diseases. The company was founded on December 19, 2011 and is headquartered in Gothenburg, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
TOL does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company